Chemical Compound

Biocytin-Mal

CAS Registry Number 102849-12-7
Back to search Request a Quote
Biocytin-Mal chemical structure
Primary Record

Biocytin-Mal

In stock
3,210 g
Purity
98.6 %
CAS
102849-12-7

Compound Identifiers & Properties

CAS
102849-12-7
PubChem CID
127195
SMILES
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)CCN3C(=O)C=CC3=O)NC(=O)N2
Canonical SMILES
O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCC[C@H](NC(=O)CCN1C(=O)C=CC1=O)C(=O)O

Names & Synonyms

  • Biocytin-Mal
  • 3-(N-Maleimidopropionyl)biocytin
  • 3-(N-Maleimidylpropionyl)biocytin
  • Biotin Impurity 30
  • N-(3-Maleimidopropionyl)biocytin
  • 3-MPB
  • RefChem:92703
  • AC1L2RLJ
  • 102849-12-7
  • AC1Q6FU8
  • 3-(N-Maleimidopropionyl)-biocytin
  • C23H33N5O7S
  • 3-(N-Maleimido-propionyl)biocytin
  • Nalpha-(3-Maleimidylpropionyl)Biocytin
  • SCHEMBL29357466
  • DTXSID90912986
  • CHEBI:184004
  • HMS3650I18
  • 1884AH
  • AR-1K5544
  • CID127195
  • MFCD16661254
  • ZINC22061958
  • FM25002
  • HY-W020784
  • 98930-71-3
  • PD019854
  • J711.315C
  • CS-0031910
  • (2S)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]hexanoic acid
  • H49804
  • N-(3-Maleimidopropionyl)biocytin, >=75% (HPLC)
  • N|A-Biotinyl-N|A-(3-maleimidopropionyl)-L-lysine
  • SR-01000946294
  • SR-01000946294-1
  • L-Lysine,N2-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
  • n2-[3-(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)propanoyl]-n6-{5-[(3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanoyl}-l-lysine
  • (2R)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]hexanoic acid
  • (2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-[3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido]hexanoic acid
  • 34551-16-1
  • L-Lysine, N2-(3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl)-N6-(5-(hexahydro-2-exo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-
  • L-Lysine, N2-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
  • MPB
  • N~2~-[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-1-hydroxypropylidene]-N~6~-[1-hydroxy-5-(2-hydroxy-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-yl)pentylidene]lysine
  • N~2~-[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-1-hydroxypropylidene]-N~6~-{1-hydroxy-5-[(3aR,6S,6aS)-2-hydroxy-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-yl]pentylidene}-L-lysine
  • N2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine
  • N2-[3-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxope ntyl]-L-lysine
  • N2-[3-(2,5-Dihydro-2,5-dioxo-1H-pyrrole-1-yl)propanoyl]-N6-[5-[(3aS,6abeta)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4alpha-yl]-1-oxopentyl]-L-lysine
  • N2-[3-(2,5-Dioxo-3-pyrroline-1-yl)propionyl]-N6-[5-[[(3aS,6abeta)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole]-4alpha-yl]-1-oxopentyl]-L-lysine
  • N2-[3-[(2,5-Dihydro-2,5-dioxo-1H-pyrrol)-1-yl]-1-oxopropyl]-N6-[5-[[(3aS,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol]-4alpha-yl]-1-oxopentyl]-L-lysine
  • N2-[3-[(2,5-Dihydro-2,5-dioxo-1H-pyrrole)-1-yl]-1-oxopropyl]-N6-[5-[[(3aS,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole]-4alpha-yl]-1-oxopentyl]-L-lysine